DFTX Operating Cash Flow (Statement)

Definium Therapeutics Inc · Operating Cash Flow (Statement)

DFTX logo

DFTX Operating Cash Flow (Statement)

Latest reported-$52.78M
DFTX Quarterly Cash from Operations (-$155.51K → -$52.78M)
High-resolution chart · PNG

DFTX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Definium Therapeutics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-52,778,000
-42,631,000
-41,891,068
-29,567,000
-29,599,000
-29,419,000
-25,351,000
-17,191,000
-19,989,000
-16,598,000
-20,563,000
-16,626,000
-13,845,000
-13,331,000
-12,849,000
-9,297,000
-15,127,000
-12,866,000
-13,900,000
-16,782,000
-11,171,000
-10,038,000
-7,141,684
-5,804,000
-5,551,000
-5,100,008
24,189
-268,848
70,668
-160,475
-136,270
-250,534
-157,489
-175,180
-73,335
-297,681
-155,506
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.